HMG CoA reductase inhibitor (statin) and aortic valve calcium
- 1 March 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 359 (9312), 1125-1126
- https://doi.org/10.1016/s0140-6736(02)08161-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Effect of HMG-CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed TomographyNew England Journal of Medicine, 1998
- Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method.Radiology, 1998
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJournal of the American College of Cardiology, 1997
- Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic StenosisArteriosclerosis, Thrombosis, and Vascular Biology, 1996